General MedicationsORALGeneric

GRIFULVIN V

GRISEOFULVIN, MICROCRYSTALLINE

Standard Dose

125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Max Dose

Refer to approved labeling

Primary Use

Marketing status: Discontinued

Summary

Approval overview GRIFULVIN V is listed in Drugs@FDA under application 050448 (NDA).

Marketing status: Discontinued Active ingredient GRISEOFULVIN, MICROCRYSTALLINE Form and strength SUSPENSION;ORAL - 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JOHNSON AND JOHNSON Submission history Latest submission status date: 1998-10-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview GRIFULVIN V is listed in Drugs@FDA under application 050448 (NDA). Marketing status: Discontinued Active ingredient GRISEOFULVIN, MICROCRYSTALLINE Form and strength SUSPENSION;ORAL - 125MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor JOHNSON AND JOHNSON Submission history Latest submission status date: 1998-10-08 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued

Interaction Notes

No interaction notes stored yet.